Biocon Ltd.’s consolidated web revenue fell 84.3% within the second quarter of fiscal 2025, lacking analysts’ estimates.
The drugmaker’s revenue declined to Rs 27.1 crore within the September quarter, as in comparison with Rs 172.7 crore within the year-ago interval, in response to an trade submitting on Wednesday. That compares with the Rs 24-crore consensus estimate of analysts tracked by Bloomberg.
"Globes" has realized that the protection firm DSIT Options, managed by Rafael Superior Protection Programs, is looking for to...
However ranging is OK, is the theme that I've been sustaining for weeks now, as a result of if worth...
Kudankulam nuclear energy vegetation | Photograph Credit score: SPECIAL ARRANGEMENT The Nuclear Energy Company of India Ltd (NPCIL) has stated that the...
A person retirement account (IRA) is a sort of funding account that permits you to save for retirement independently of...
The world economic system has been "surprisingly resilient" within the face of adversity this yr, the OECD stated Tuesday, elevating...
Get the latest news and follow the coverage of Investing, World News, Stocks, Market Analysis, Business & Financial News, and more from the top trusted sources.
